Skip to main content
. 2024 Dec 10;25(4):192–199. doi: 10.4274/jtgga.galenos.2024.2024-2-9

Table 2. Embryologic and pregnancy outcomes of PCOS patients categorized by luteinizing hormone levels: upper 50% (7.1-29.0 IU/L) vs. lower 50% (1.0-7.0 IU/L).

Variable

Lower 50% LH, (n=38)

Upper 50% LH, (n=38)

p-value

Number of oocytes collected

26.8±7.4

27.3±9.6

0.82

Number of MII oocytes

19.9±6.8

20.2±7.8

0.88

MII fertilized (%)

75.1±16.2

73.9±18.8

0.78

2PN grew to blastocyst (%)

47.4±23.0

55.0%±27.0

0.18

MII grew to blastocyst (%)

34.9±18.0

39.8±18.8

0.25

Number of embryos frozen

6.9±4.4

8.24±5.1

0.25

Clinical pregnancy no. (%)

13 (34.2)

17 (44.7)

0.35

Miscarriage no/total pregnancies (%)

12/23 (52%)

7/18 (39%)

0.40

Live birth no. (%)

8 (21.0)

12 (31.6)

0.29

Data are presented as mean ± standard deviation, PCOS: Polycystic ovary syndrome, LH: Luteinizing hormone, MII oocytes: Mature oocytes, 2PN: 2 pronuclei stage